Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06044077 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial to Evaluate the Immunogenicity and Safety of the 23-valent Pneumococcal Polysaccharide Vaccine in Healthy People

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated September 21, 2023 (before its estimated March 8, 2024 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
This study is a randomized, blinded, parallel controlled phase 3 clinical trial to evaluate the immunogenicity and safety of the 23-valent pneumococcal polysaccharide vaccine in healthy people aged 2 years and above.
Trial Details
NCT Number NCT06044077
Lead Sponsor Aimei Vacin BioPharm (Zhejiang) Co., Ltd.
Conditions
(from sponsor)		 Pneumococcal Disease
Related terms Pneumococcal Infections
Enrollment 1,920 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov